Wave Life Sciences (WVE) Cash from Investing Activities (2016 - 2025)
Wave Life Sciences' Cash from Investing Activities history spans 11 years, with the latest figure at $1000.0 for Q4 2025.
- For Q4 2025, Cash from Investing Activities rose 101.16% year-over-year to $1000.0; the TTM value through Dec 2025 reached -$718000.0, up 23.45%, while the annual FY2025 figure was -$718000.0, 23.45% up from the prior year.
- Cash from Investing Activities reached $1000.0 in Q4 2025 per WVE's latest filing, up from -$248000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $24.8 million in Q4 2022 to a low of -$50.2 million in Q1 2022.
- Average Cash from Investing Activities over 5 years is -$229300.0, with a median of -$181500.0 recorded in 2023.
- The largest YoY upside for Cash from Investing Activities was 165700.0% in 2022 against a maximum downside of 46388.89% in 2022.
- A 5-year view of Cash from Investing Activities shows it stood at -$15000.0 in 2021, then skyrocketed by 165700.0% to $24.8 million in 2022, then crashed by 101.43% to -$356000.0 in 2023, then surged by 75.84% to -$86000.0 in 2024, then surged by 101.16% to $1000.0 in 2025.
- Per Business Quant, the three most recent readings for WVE's Cash from Investing Activities are $1000.0 (Q4 2025), -$248000.0 (Q3 2025), and -$306000.0 (Q2 2025).